Trial Profile
Effects of Probiotics Intake on Oral Microbiome and Mucosa Inflammation in Patients With Cytotoxic Therapy Induced Oral Mucositis: A Pilot Study
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Limosilactobacillus reuteri (Primary)
- Indications Stomatitis
- Focus Therapeutic Use
- 25 Feb 2019 Status changed to recruiting.
- 23 Aug 2018 Status changed from not yet recruiting to active, no longer recruiting.
- 14 Jun 2018 New trial record